Karen Dado - Managing Director, Health and Life Sciences
Karen Dado has spent over twenty years providing management consulting and corporate advisory services in the health care and life sciences sectors. She spent 15 years with PricewaterhouseCoopers in their London and Sydney offices, advising health and biotech clients. Karen has extensive experience in undertaking: strategic reviews, commercial feasibility studies, cost benefit analyses and risk management reviews in the life sciences sector. Clients have included private equity firms, universities and research institutes, rural research and development corporations, industry associations, pharmaceutical companies and biotech companies. Karen is a member of Merck's Science Alliance providing commercial advice on potential biopharmaceutical investments.
Specific examples of her work are provided below:
Analyse performance and understand key value drivers Develop strategies for differentiation to maximise value Achieve sustainability and effective commercialisation Benchmarking or audit to identify gap between strategic intent and delivery Redesign of business processes including time-to-market to improve their efficiency and effectiveness Best practice governance and reporting frameworks to sustain performance gains Independent experts reports, commercial due diligence and business planning to support commercialisation Capital raising, sale and acquisition and integration planning to identify the associated synergies and costs.
EMS Price at posting:
7.9¢ Sentiment: None Disclosure: Held
